Karin Rosen
Direttore Tecnico/Scientifico/R&S presso HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
Posizioni attive di Karin Rosen
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Direttore Tecnico/Scientifico/R&S | 02/11/2020 | - |
| DIAMYD MEDICAL AB | Direttore/Membro del Consiglio | 10/03/2023 | - |
Storia della carriera di Karin Rosen
Precedenti posizioni note di Karin Rosen
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| GSK PLC | Corporate Officer/Principal | 01/11/2018 | 01/11/2020 |
Formazione di Karin Rosen
| University of Lund | Doctorate Degree |
Statistiche
Distribuzione geografica
| Svezia | 3 |
| Irlanda | 2 |
| Regno Unito | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| GSK PLC | Health Technology |
| DIAMYD MEDICAL AB | Health Technology |
| Aziende private | 1 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
- Borsa valori
- Insiders
- Karin Rosen
- Esperienza
